Display options
Cite
Blessin NC, Li W, Mandelkow T, et al. Prognostic role of proliferating CD8. Cell Oncol (Dordr). 2021;44(4):793-803doi: 10.1007/s13402-021-00601-4.
Blessin, N. C., Li, W., Mandelkow, T., Jansen, H. L., Yang, C., Raedler, J. B., Simon, R., Büscheck, F., Dum, D., Luebke, A. M., Hinsch, A., Möller, K., Menz, A., Bernreuther, C., Lebok, P., Clauditz, T., Sauter, G., Marx, A., Uhlig, R., Wilczak, W., Minner, S., Krech, T., Fraune, C., Höflmayer, D., Burandt, E., & Steurer, S. (2021). Prognostic role of proliferating CD8. Cellular oncology (Dordrecht), 44(4), 793-803. https://doi.org/10.1007/s13402-021-00601-4
Blessin, Niclas C, et al. "Prognostic role of proliferating CD8." Cellular oncology (Dordrecht) vol. 44,4 (2021): 793-803. doi: https://doi.org/10.1007/s13402-021-00601-4
Blessin NC, Li W, Mandelkow T, Jansen HL, Yang C, Raedler JB, Simon R, Büscheck F, Dum D, Luebke AM, Hinsch A, Möller K, Menz A, Bernreuther C, Lebok P, Clauditz T, Sauter G, Marx A, Uhlig R, Wilczak W, Minner S, Krech T, Fraune C, Höflmayer D, Burandt E, Steurer S. Prognostic role of proliferating CD8. Cell Oncol (Dordr). 2021 Aug;44(4):793-803. doi: 10.1007/s13402-021-00601-4. Epub 2021 Apr 17. PMID: 33864611; PMCID: PMC8338812.
Copy Download .nbib Format: NLM
Share it on

Cell Oncol (Dordr). 2021 Aug;44(4):793-803. doi: 10.1007/s13402-021-00601-4. Epub 2021 Apr 17.

Prognostic role of proliferating CD8.

Cellular oncology (Dordrecht)

Niclas C Blessin, Wenchao Li, Tim Mandelkow, Hannah L Jansen, Cheng Yang, Jonas B Raedler, Ronald Simon, Franziska Büscheck, David Dum, Andreas M Luebke, Andrea Hinsch, Katharina Möller, Anne Menz, Christian Bernreuther, Patrick Lebok, Till Clauditz, Guido Sauter, Andreas Marx, Ria Uhlig, Waldemar Wilczak, Sarah Minner, Till Krech, Christoph Fraune, Doris Höflmayer, Eike Burandt, Stefan Steurer

Affiliations

  1. Institute of Pathology, University Medical Centre Hamburg-Eppendorf, Martinistraße 52, D-20246, Hamburg, Germany.
  2. College of Arts and Sciences, Boston University, Boston, MA, USA.
  3. Institute of Pathology, University Medical Centre Hamburg-Eppendorf, Martinistraße 52, D-20246, Hamburg, Germany. [email protected].
  4. Institute of Pathology, Medical Centre Fürth, D-90766, Fürth, Germany.

PMID: 33864611 PMCID: PMC8338812 DOI: 10.1007/s13402-021-00601-4

Abstract

PURPOSE: Expansion of CD8

METHODS: To understand the CD8

RESULTS: The density and the percentage of proliferating (Ki67

CONCLUSION: Our data demonstrate a tumor type dependent prognostic impact of proliferating (Ki67

© 2021. The Author(s).

Keywords: Breast cancer; CD8+ cytotoxic Tcells; Colorectal cancer; Gastric cancer; Ovarian cancer; Pancreatic cancer; Renal cell cancer; Tumor microenvironment

References

  1. N.C. Blessin, P. Spriestersbach, W. Li, T. Mandelkow, D. Dum, R. Simon, C. Hube-Magg, F. Lutz, F. Viehweger, M. Lennartz, C. Fraune, V. Nickelsen, W. Fehrle, C. Gobel, S. Weidemann, T. Clauditz, P. Lebok, K. Moller, S. Steurer, J.R. Izbicki, G. Sauter, S. Minner, F. Jacobsen, A.M. Luebke, F. Buscheck, D. Hoflmayer, W. Wilczak, E. Burandt, A. Hinsch, Prevalence of CD8(+) cytotoxic lymphocytes in human neoplasms. Cell. Oncol. 43, 421–430 (2020) - PubMed
  2. J. Galon, A. Costes, F. Sanchez-Cabo, A. Kirilovsky, B. Mlecnik, C. Lagorce-Pages, M. Tosolini, M. Camus, A. Berger, P. Wind, F. Zinzindohoue, P. Bruneval, P.H. Cugnenc, Z. Trajanoski, W.H. Fridman, F. Pages, Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 313, 1960–1964 (2006) - PubMed
  3. J. Galon, F. Pages, F.M. Marincola, M. Thurin, G. Trinchieri, B.A. Fox, T.F. Gajewski, P.A. Ascierto, The immune score as a new possible approach for the classification of cancer. J. Transl. Med. 10, 1 (2012) - PubMed
  4. P.C. Tumeh, C.L. Harview, J.H. Yearley, I.P. Shintaku, E.J. Taylor, L. Robert, B. Chmielowski, M. Spasic, G. Henry, V. Ciobanu, A.N. West, M. Carmona, C. Kivork, E. Seja, G. Cherry, A.J. Gutierrez, T.R. Grogan, C. Mateus, G. Tomasic, J.A. Glaspy, R.O. Emerson, H. Robins, R.H. Pierce, D.A. Elashoff, C. Robert, A. Ribas, PD-1 blockade induces responses by inhibiting adaptive immune resistance. Nature 515, 568–571 (2014) - PubMed
  5. W. Yao, J.C. He, Y. Yang, J.M. Wang, Y.W. Qian, T. Yang, L. Ji, The prognostic value of tumor-infiltrating lymphocytes in hepatocellular carcinoma: A systematic review and meta-analysis. Sci. Rep. 7, 7525 (2017) - PubMed
  6. D.S. Chen, I. Mellman, Elements of cancer immunity and the cancer-immune set point. Nature 541, 321–330 (2017) - PubMed
  7. G.L. Beatty, W.L. Gladney, Immune escape mechanisms as a guide for cancer immunotherapy. Clin. Cancer Res. 21, 687–692 (2015) - PubMed
  8. P.S. Hegde, V. Karanikas, S. Evers, The where, the when, and the how of immune monitoring for cancer immunotherapies in the era of checkpoint inhibition. Clin. Cancer Res. 22, 1865–1874 (2016) - PubMed
  9. L. Galluzzi, A. Buque, O. Kepp, L. Zitvogel, G. Kroemer, Immunological effects of conventional chemotherapy and targeted anticancer agents. Cancer Cell 28, 690–714 (2015) - PubMed
  10. R.S. Herbst, J.C. Soria, M. Kowanetz, G.D. Fine, O. Hamid, M.S. Gordon, J.A. Sosman, D.F. McDermott, J.D. Powderly, S.N. Gettinger, H.E. Kohrt, L. Horn, D.P. Lawrence, S. Rost, M. Leabman, Y. Xiao, A. Mokatrin, H. Koeppen, P.S. Hegde, I. Mellman, D.S. Chen, F.S. Hodi, Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients. Nature 515, 563–567 (2014) - PubMed
  11. S. Halle, K.A. Keyser, F.R. Stahl, A. Busche, A. Marquardt, X. Zheng, M. Galla, V. Heissmeyer, K. Heller, J. Boelter, K. Wagner, Y. Bischoff, R. Martens, A. Braun, K. Werth, A. Uvarovskii, H. Kempf, M. Meyer-Hermann, R. Arens, M. Kremer, G. Sutter, M. Messerle, R. Forster, In vivo killing capacity of cytotoxic T cells is limited and involves dynamic interactions and T cell Cooperativity. Immunity 44, 233–245 (2016) - PubMed
  12. S.E. Stanton, M.L. Disis, Clinical significance of tumor-infiltrating lymphocytes in breast cancer. J. Immunother. Cancer 4, 59 (2016) - PubMed
  13. M. Uso, E. Jantus-Lewintre, R.M. Bremnes, S. Calabuig, A. Blasco, E. Pastor, I. Borreda, S. Molina-Pinelo, L. Paz-Ares, R. Guijarro, M. Martorell, J. Forteza, C. Camps, R. Sirera, Analysis of the immune microenvironment in resected non-small cell lung cancer: The prognostic value of different T lymphocyte markers. Oncotarget 7, 52849–52861 (2016) - PubMed
  14. R.D. Gartrell, D.K. Marks, T.D. Hart, G. Li, D.R. Davari, A. Wu, Z. Blake, Y. Lu, K.N. Askin, A. Monod, C.L. Esancy, E.C. Stack, D.T. Jia, P.M. Armenta, Y. Fu, D. Izaki, B. Taback, R. Rabadan, H.L. Kaufman, C.G. Drake, B.A. Horst, Y.M. Saenger, Quantitative analysis of immune infiltrates in primary melanoma. Cancer Immunol. Res. 6, 481–493 (2018) - PubMed
  15. Y. Naito, K. Saito, K. Shiiba, A. Ohuchi, K. Saigenji, H. Nagura, H. Ohtani, CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer. Cancer Res. 58, 3491–3494 (1998) - PubMed
  16. O. Nakano, M. Sato, Y. Naito, K. Suzuki, S. Orikasa, M. Aizawa, Y. Suzuki, I. Shintaku, H. Nagura, H. Ohtani, Proliferative activity of intratumoral CD8(+) T-lymphocytes as a prognostic factor in human renal cell carcinoma: Clinicopathologic demonstration of antitumor immunity. Cancer Res. 61, 5132–5136 (2001) - PubMed
  17. N.A. Giraldo, E. Becht, F. Pages, G. Skliris, V. Verkarre, Y. Vano, A. Mejean, N. Saint-Aubert, L. Lacroix, I. Natario, A. Lupo, M. Alifano, D. Damotte, A. Cazes, F. Triebel, G.J. Freeman, M.C. Dieu-Nosjean, S. Oudard, W.H. Fridman, C. Sautes-Fridman, Orchestration and prognostic significance of immune checkpoints in the microenvironment of primary and metastatic renal cell cancer. Clin. Cancer Res. 21, 3031–3040 (2015) - PubMed
  18. T. Chiba, H. Ohtani, T. Mizoi, Y. Naito, E. Sato, H. Nagura, A. Ohuchi, K. Ohuchi, K. Shiiba, Y. Kurokawa, S. Satomi, Intraepithelial CD8+ T-cell-count becomes a prognostic factor after a longer follow-up period in human colorectal carcinoma: Possible association with suppression of micrometastasis. Br. J. Cancer 91, 1711–1717 (2004) - PubMed
  19. J. Gerdes, U. Schwab, H. Lemke, H. Stein, Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int. J. Cancer 31, 13–20 (1983) - PubMed
  20. A. Soares, L. Govender, J. Hughes, W. Mavakla, M. de Kock, C. Barnard, B. Pienaar, E. Janse van Rensburg, G. Jacobs, G. Khomba, L. Stone, B. Abel, T.J. Scriba, W.A. Hanekom, Novel application of Ki67 to quantify antigen-specific in vitro lymphoproliferation. J. Immunol. Methods 362, 43–50 (2010) - PubMed
  21. N. Zhang, M.J. Bevan, CD8(+) T cells: Foot soldiers of the immune system. Immunity 35, 161–168 (2011) - PubMed
  22. K. Imaizumi, T. Suzuki, M. Kojima, M. Shimomura, N. Sakuyama, Y. Tsukada, T. Sasaki, Y. Nishizawa, A. Taketomi, M. Ito, T. Nakatsura, Ki67 expression and localization of T cells after neoadjuvant therapies as reliable predictive markers in rectal cancer. Cancer Sci. 111, 23–35 (2020) - PubMed
  23. W. Shah, X. Yan, L. Jing, Y. Zhou, H. Chen, Y. Wang, A reversed CD4/CD8 ratio of tumor-infiltrating lymphocytes and a high percentage of CD4(+)FOXP3(+) regulatory T cells are significantly associated with clinical outcome in squamous cell carcinoma of the cervix. Cell. Mol. Immunol. 8, 59–66 (2011) - PubMed
  24. J. Kononen, L. Bubendorf, A. Kallioniemi, M. Barlund, P. Schraml, S. Leighton, J. Torhorst, M.J. Mihatsch, G. Sauter, O.P. Kallioniemi, Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat. Med. 4, 844–847 (1998) - PubMed
  25. S. Tippmann, Programming tools: Adventures with R. Nature 517, 109–110 (2015) - PubMed
  26. R-Core-Team, R: A language and environment for statistical computing, R Foundation for Statistical Computing, Vienna, Austria. URL https://www.R-project.org/ . (2018). Accessed 01.12.2019 - PubMed
  27. X. Hu, Y.Q. Li, Q.G. Li, Y.L. Ma, J.J. Peng, S.J. Cai, ITGAE defines CD8+ tumor-infiltrating lymphocytes predicting a better prognostic survival in colorectal Cancer. EBioMedicine 35, 178–188 (2018) - PubMed
  28. G.E. Idos, J. Kwok, N. Bonthala, L. Kysh, S.B. Gruber, C. Qu, The prognostic implications of tumor infiltrating lymphocytes in colorectal cancer: A systematic review and meta-analysis. Sci. Rep. 10, 3360 (2020) - PubMed
  29. Y. Mao, Q. Qu, X. Chen, O. Huang, J. Wu, K. Shen, The prognostic value of tumor-infiltrating lymphocytes in breast cancer: A systematic review and meta-analysis. PLoS One 11, e0152500 (2016) - PubMed
  30. J.S. Lee, H.S. Won, S. Sun, J.H. Hong, Y.H. Ko, Prognostic role of tumor-infiltrating lymphocytes in gastric cancer: A systematic review and meta-analysis. Medicine (Baltimore) 97, e11769 (2018) - PubMed
  31. J. Li, J. Wang, R. Chen, Y. Bai, X. Lu, The prognostic value of tumor-infiltrating T lymphocytes in ovarian cancer. Oncotarget 8, 15621–15631 (2017) - PubMed
  32. F. Guo, Y. Dong, Q. Tan, J. Kong, B. Yu, Tissue infiltrating immune cells as prognostic biomarkers in endometrial cancer: A meta-analysis. Dis. Markers 2020, 1805764 (2020) - PubMed
  33. X. Zheng, X. Song, Y. Shao, B. Xu, W. Hu, Q. Zhou, L. Chen, D. Zhang, C. Wu, J. Jiang, Prognostic role of tumor-infiltrating lymphocytes in esophagus cancer: A meta-analysis. Cell. Physiol. Biochem. 45, 720–732 (2018) - PubMed
  34. Y. Masugi, T. Abe, A. Ueno, Y. Fujii-Nishimura, H. Ojima, Y. Endo, Y. Fujita, M. Kitago, M. Shinoda, Y. Kitagawa, M. Sakamoto, Characterization of spatial distribution of tumor-infiltrating CD8(+) T cells refines their prognostic utility for pancreatic cancer survival. Mod. Pathol. 32, 1495–1507 (2019) - PubMed
  35. T.A. Barnes, E. Amir, HYPE or HOPE: The prognostic value of infiltrating immune cells in cancer. Br. J. Cancer 117, 451–460 (2017) - PubMed
  36. Reiswich, N. Blessin, A. Rolschewski, F. Lutz, T. Mandelkow, W. Li, W. Yang, R. Simon, F. Büscheck, R. Uhlig, L. Wölber, S. Mahner, N. De Gregorio, R. Klapdor, M. Kalder, S. Steurer, W. Wilczak, C. Fraune and E. Burandt, T cell density at the invasive margin and immune phenotypes predict patient’s outcome in vulvar carcinomas, Unpublished (2021)  - PubMed
  37. N.C. Blessin, R. Abu-Hashem, T. Mandelkow, W. Li, R. Simon, C. Hube-Magg, C. Möller-Koop, M. Witt, F. Büscheck, C. Fraune, A.M. Luebke, K. Möller, J. Jacobsen, F. Lutz, M. Lennartz, S. Steurer, G. Sauter, D. Höflmayer, M.C. Tsourlakis, A. Hinsch, E. Burandt, W. Wilczak, S. Minner and T. Clauditz, Prevalence of proliferating CD8+ cells in normal lymphatic tissues, inflammation and cancer, Unpublished (2021)  - PubMed
  38. R.L. Giuntoli 2nd, J. Lu, H. Kobayashi, R. Kennedy, E. Celis, Direct costimulation of tumor-reactive CTL by helper T cells potentiate their proliferation, survival, and effector function. Clin. Cancer Res. 8, 922–931 (2002) - PubMed
  39. M. Motamedi, L. Xu, S. Elahi, Correlation of transferrin receptor (CD71) with Ki67 expression on stimulated human and mouse T cells: The kinetics of expression of T cell activation markers. J. Immunol. Methods 437, 43–52 (2016) - PubMed
  40. A.O. Kamphorst, R.N. Pillai, S. Yang, T.H. Nasti, R.S. Akondy, A. Wieland, G.L. Sica, K. Yu, L. Koenig, N.T. Patel, M. Behera, H. Wu, M. McCausland, Z. Chen, C. Zhang, F.R. Khuri, T.K. Owonikoko, R. Ahmed, S.S. Ramalingam, Proliferation of PD-1+ CD8 T cells in peripheral blood after PD-1-targeted therapy in lung cancer patients. Proc. Natl. Acad. Sci. U. S. A. 114, 4993–4998 (2017) - PubMed
  41. A. Maity, R. Mick, A.C. Huang, S.M. George, M.D. Farwell, J.N. Lukens, A.T. Berman, T.C. Mitchell, J. Bauml, L.M. Schuchter, M. O'Hara, L.L. Lin, A. Demichele, J.P. Christodouleas, N.B. Haas, D.M. Patsch, S.M. Hahn, A.J. Minn, E.J. Wherry, R.H. Vonderheide, A phase I trial of pembrolizumab with hypofractionated radiotherapy in patients with metastatic solid tumours. Br. J. Cancer 119, 1200–1207 (2018) - PubMed
  42. M. Ahmadzadeh, L.A. Johnson, B. Heemskerk, J.R. Wunderlich, M.E. Dudley, D.E. White, S.A. Rosenberg, Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired. Blood 114, 1537–1544 (2009) - PubMed
  43. A.P. Ganesan, J. Clarke, O. Wood, E.M. Garrido-Martin, S.J. Chee, T. Mellows, D. Samaniego-Castruita, D. Singh, G. Seumois, A. Alzetani, E. Woo, P.S. Friedmann, E.V. King, G.J. Thomas, T. Sanchez-Elsner, P. Vijayanand, C.H. Ottensmeier, Tissue-resident memory features are linked to the magnitude of cytotoxic T cell responses in human lung cancer. Nat. Immunol. 18, 940–950 (2017) - PubMed
  44. X. Liu, R.M. Gibbons, S.M. Harrington, C.J. Krco, S.N. Markovic, E.D. Kwon, H. Dong, Endogenous tumor-reactive CD8(+) T cells are differentiated effector cells expressing high levels of CD11a and PD-1 but are unable to control tumor growth. Oncoimmunology 2, e23972 (2013) - PubMed
  45. E.D. Thompson, H.L. Enriquez, Y.X. Fu, V.H. Engelhard, Tumor masses support naive T cell infiltration, activation, and differentiation into effectors. J. Exp. Med. 207, 1791–1804 (2010) - PubMed
  46. S.J. Golby, C. Chinyama, J. Spencer, Proliferation of T-cell subsets that contact tumour cells in colorectal cancer. Clin. Exp. Immunol. 127, 85–91 (2002) - PubMed
  47. V. Golubovskaya and L. Wu, Different subsets of T cells, memory, effector functions, and CAR-T immunotherapy, Cancers (Basel) 8, 36 (2016) - PubMed
  48. B. Mlecnik, G. Bindea, H.K. Angell, M.S. Sasso, A.C. Obenauf, T. Fredriksen, L. Lafontaine, A.M. Bilocq, A. Kirilovsky, M. Tosolini, M. Waldner, A. Berger, W.H. Fridman, A. Rafii, V. Valge-Archer, F. Pages, M.R. Speicher, J. Galon, Functional network pipeline reveals genetic determinants associated with in situ lymphocyte proliferation and survival of cancer patients. Sci. Transl. Med. 6, 228ra237 (2014) - PubMed
  49. M.L. Eich, A. Chaux, M.A. Mendoza Rodriguez, G. Guner, D. Taheri, M.D.C. Rodriguez Pena, R. Sharma, M.E. Allaf, G.J. Netto, Tumour immune microenvironment in primary and metastatic papillary renal cell carcinoma. Histopathology 76, 423–432 (2020) - PubMed
  50. J.M. Kim, D.S. Chen, Immune escape to PD-L1/PD-1 blockade: Seven steps to success (or failure). Ann. Oncol. 27, 1492–1504 (2016) - PubMed
  51. S. Edin, T. Kaprio, J. Hagstrom, P. Larsson, H. Mustonen, C. Bockelman, K. Strigard, U. Gunnarsson, C. Haglund, R. Palmqvist, The prognostic importance of CD20(+) B lymphocytes in colorectal Cancer and the relation to other immune cell subsets. Sci. Rep. 9, 19997 (2019) - PubMed
  52. R. Matkowski, I. Gisterek, A. Halon, A. Lacko, K. Szewczyk, U. Staszek, M. Pudelko, B. Szynglarewicz, J. Szelachowska, A. Zolnierek, J. Kornafel, The prognostic role of tumor-infiltrating CD4 and CD8 T lymphocytes in breast cancer. Anticancer Res. 29, 2445–2451 (2009) - PubMed
  53. B. Shang, Y. Liu, S.J. Jiang, Y. Liu, Prognostic value of tumor-infiltrating FoxP3+ regulatory T cells in cancers: A systematic review and meta-analysis. Sci. Rep. 5, 15179 (2015) - PubMed

Publication Types